Benzinga | Apr 21, 2021 08:48AM EDT

Piper Sandler Maintains Overweight on Edwards Lifesciences, Raises Price Target to $105

Piper Sandler analyst Adam Maeder maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $97 to $105.